Breaking news

Google’s AI Mode: The Future Of Search Or The End Of The Blue Links Era?

Google is rewriting the rules of search. With the rollout of its experimental AI Mode, the tech giant is moving away from the traditional list of ten blue links, replacing them with AI-generated summaries. This shift marks one of the most significant transformations in Google Search’s history, bringing AI closer to the core user experience.

From AI Overviews To Full AI-Generated Results

Google has been gradually integrating AI into search, first with AI Overviews, which provide quick, AI-generated answers at the top of search results. AI Mode, however, takes this further. Instead of just a snippet, it generates an entire page of AI-driven insights, using the advanced Gemini 2.0 model, known for its reasoning and multimodal capabilities.

For users opting into Google One AI Premium ($19.99/month), the feature is available via the AI Mode tab in Search Labs. When enabled, it not only provides AI-crafted responses but also includes hyperlinks to relevant sources—addressing concerns about AI diminishing web traffic.

In one example, a query about sleep trackers produced a detailed AI-generated comparison table, showcasing options side by side. Multimodal capabilities also allow users to input queries using text, voice, or images, bringing a more interactive element to search.

A Strategic Move Amid Rising Competition

Google’s parent company, Alphabet, reported $350 billion in revenue in 2024, with search advertising as its primary cash engine. However, with OpenAI (backed by Microsoft) pushing conversational AI as an alternative to traditional search, Google is under pressure to innovate while protecting its lucrative ad business.

AI Mode hints at a future where ads blend seamlessly into AI-generated results, potentially reshaping digital advertising. Alphabet’s investment chief, Ruth Porat, highlighted AI as a key focus at the Reuters NEXT conference, reinforcing that search remains central to Google’s AI-driven strategy.

Challenges And Legal Pushback

Not everyone is on board with Google’s AI-driven search evolution. Content creators and publishers have raised concerns that AI-generated summaries could reduce traffic to original sources. Chegg, an education platform, has already accused Google of undermining original content, underscoring the growing friction between AI advancements and traditional content-based business models.

The Future Of Search

With 100 countries already experiencing AI Overviews and AI Mode expanding to early testers, Google is betting big on AI-powered search. Whether this transition enhances user experience or disrupts the internet’s content ecosystem remains to be seen. But one thing is clear: the search engine as we know it is undergoing its most radical transformation yet.

Medochemie And Theramir Announce Strategic Investment Agreement To Advance Biotech Manufacturing In Cyprus

Pharmaceutical manufacturer Medochemie and biotechnology company Theramir, both Cyprus-based, have announced a strategic investment agreement and collaboration aimed at developing next-generation biological therapies and expanding manufacturing capabilities in Cyprus.

The agreement, announced on 2 September 2026, brings together Medochemie’s experience in pharmaceutical manufacturing and Theramir’s biotechnology research. The companies said the collaboration would support advanced pharmaceutical manufacturing in Cyprus and south-eastern Europe.

What The Partnership Covers

Medochemie’s contribution will include its expertise in manufacturing sterile therapeutic products and its access to international markets.

Theramir develops technologies based on extracellular vesicles and microRNAs. Its work includes using stem-cell-derived extracellular vesicles to deliver microRNAs, small, non-coding RNA molecules that regulate genes and biological pathways associated with cancer growth and metastasis.

Under the agreement, the companies will jointly support the development of “Good Manufacturing Practice” capabilities for next-generation biological therapies. The partnership is also intended to help move these therapies towards clinical development.

A Wider Role For Cyprus

The collaboration will also support Theramir’s wider research programme. According to the companies, it is intended to strengthen Cyprus’s biotechnology infrastructure and expand local capacity in next-generation biomanufacturing.

They present the agreement as a step towards giving Cyprus a larger role in biotechnology and advanced pharmaceutical manufacturing for south-eastern Europe and international markets.

The Future Forbes Realty Global Properties
eCredo
Aretilaw firm
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter